BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 30185601)

  • 1. Structural insights into the functional diversity of the CDK-cyclin family.
    Wood DJ; Endicott JA
    Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bound to activate: conformational consequences of cyclin binding to CDK2.
    Radzio-Andzelm E; Lew J; Taylor S
    Structure; 1995 Nov; 3(11):1135-41. PubMed ID: 8591024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in cyclin-dependent kinase biochemical and structural studies.
    Echalier A; Endicott JA; Noble ME
    Biochim Biophys Acta; 2010 Mar; 1804(3):511-9. PubMed ID: 19822225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural dissection of cyclin dependent kinases regulation and protein recognition properties.
    Lolli G
    Cell Cycle; 2010 Apr; 9(8):1551-61. PubMed ID: 20372077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
    Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinases: inhibition and substrate recognition.
    Endicott JA; Noble ME; Tucker JA
    Curr Opin Struct Biol; 1999 Dec; 9(6):738-44. PubMed ID: 10607671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle. Confirmational change.
    Pines J
    Nature; 1995 Jul; 376(6538):294-5. PubMed ID: 7630391
    [No Abstract]   [Full Text] [Related]  

  • 11. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of CDK/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression.
    Loyer P; Trembley JH
    Semin Cell Dev Biol; 2020 Nov; 107():36-45. PubMed ID: 32446654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of Cyclin-Dependent Kinase Fusion Complexes for In Vitro Analysis.
    Kõivomägi M
    Methods Mol Biol; 2021; 2329():95-109. PubMed ID: 34085218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structuring cell-cycle biology.
    Levine K; Cross FR
    Structure; 1995 Nov; 3(11):1131-4. PubMed ID: 8591023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Less-well known functions of cyclin/CDK complexes.
    Palmer N; Kaldis P
    Semin Cell Dev Biol; 2020 Nov; 107():54-62. PubMed ID: 32386818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the mediator subunit cyclin C and its implications for CDK8 function.
    Hoeppner S; Baumli S; Cramer P
    J Mol Biol; 2005 Jul; 350(5):833-42. PubMed ID: 15979093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
    Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
    Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iterative conversion of cyclin binding groove peptides into druglike CDK inhibitors with antitumor activity.
    Premnath PN; Craig SN; Liu S; Anderson EL; Grigoroudis AI; Kontopidis G; Perkins TL; Wyatt MD; Pittman DL; McInnes C
    J Med Chem; 2015 Jan; 58(1):433-42. PubMed ID: 25454794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
    Jeffrey PD; Tong L; Pavletich NP
    Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of cyclin A.
    Brown NR; Noble ME; Endicott JA; Garman EF; Wakatsuki S; Mitchell E; Rasmussen B; Hunt T; Johnson LN
    Structure; 1995 Nov; 3(11):1235-47. PubMed ID: 8591034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.